Bosentan hydrate is a dual endothelin receptor antagonist primarily indicated for the management of pulmonary arterial hypertension. By inhibiting the binding of endothelin-1 to its receptors, this medication… Read more
![Chemical structure of 2-((6-((4-(tert-Butyl)phenyl)sulfonamido)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)oxy)ethyl Acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1160515-53-6-2-6-4-tert-Butylphenylsulfonamido-5-2-methoxyphenoxy-22-bipyrimidin-4-yloxyethyl-Acetate.png&w=3840&q=75)



![Chemical structure of 4-(tert-Butyl)-N-(5-(2-methoxyphenoxy)-6-(vinyloxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1257099-44-7-4-tert-Butyl-N-5-2-methoxyphenoxy-6-vinyloxy-22-bipyrimidin-4-ylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of 4-(tert-Butyl)-N-(6-(2-(2-hydroxyethoxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1257099-43-6-4-tert-Butyl-N-6-2-2-hydroxyethoxyethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-ylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of 4-(tert-Butyl)-N-(6-ethoxy-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F157415-45-7-4-tert-Butyl-N-6-ethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-ylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of 4-(tert-Butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F150727-06-3-4-tert-Butyl-N-6-chloro-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-benzenesulfonamide.png&w=3840&q=75)
![Chemical structure of 4-(tert-Butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F174227-14-6-4-tert-Butyl-N-6-hydroxy-5-2-methoxyphenoxy-22-bipyrimidin-4-ylbenzenesulfonamide.png&w=3840&q=75)






![Chemical structure of N,N'-[5-(2-Methoxyphenoxy)[2,2'-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1218951-81-5-NN-5-2-Methoxyphenoxy22-bipyrimidine-46-diylbis4-11-dimethylethylbenzenesulfonamide.png&w=3840&q=75)
Bosentan hydrate is a dual endothelin receptor antagonist primarily indicated for the management of pulmonary arterial hypertension. By inhibiting the binding of endothelin-1 to its receptors, this medication prevents the vasoconstriction responsible for elevated vascular pressure. To ensure the safety and efficacy of the final pharmaceutical product, laboratories require high-quality materials for analytical testing. This collection provides reference standards, including impurities, known metabolites, and stable isotope labelled compounds, which are essential for routine quality control. These materials support the development and validation of analytical methods, allowing researchers to monitor drug degradation, identify unknown peaks during impurity profiling, and quantify active pharmaceutical ingredients with precision. Such comprehensive analytical tools are vital for maintaining compliance with regulatory standards during the manufacturing and characterization of this therapeutic agent.